Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.
Non-Executive Director: |
Timothy J Sykes |
Senior Independent Non-Executive Director: |
Angela Hildreth |
Interim Chairman: |
Ian David Gilham |
Chief Technical Officer: |
David Harry John Bunka |
Independent Non-Executive Director: |
John David Richards |
Interim CEO: |
Rob Quinn |
Address: |
Windmill House, Innovation Way, Heslington, York, United Kingdom |
Phone: |
+44 (0)1904 567 790 |
Fax: |
|
Website: |
http://aptamergroup.com/ |
Email: |
|